chrisvoncsefalvay/vaers-outcomes huggingface dataset:
This child was positive for chicken pox, tactile temp for 2 days, less than 50 lesions. 3 siblings, mother , uncle , and housemate, positive for chicken pox.
Pt reported "lightheadedness, headache,  heart flutter, tightness in chest, Post COVID vaccine IM within 15 minutes of injection. Heart rate 92-100 and regular. First BP 133/79 second BP after 5minute 129/75. Pt sated I have a history of heart arrhythmias and I don't feel right" Pt  agreed to further medical evaluation in ED. transported.
feel lightheaded; tired; couldn't relax; a slight fever; she feels hot after getting the vaccine; I was sweating a little more than normal on my forehead; my joint pain was more than normal; I had something already bothering my left foot on my toe; Headache; This is a spontaneous report received from a contactable consumer who reported for herself. This report is also reported from a Pfizer sponsored. A 69-year-old female patient received her first dose of BNT162B2 (Pfizer-BioNTech Covid-19 vaccine) via an unspecified route of administration at 0.3 mg as a single dose on 18Jun2021 (lot number EW0179, expiration date Aug2021), for COVID-19 immunization. The patient had food allergies and weather issues like when the seasons change like pollen. Concomitant medications were not reported. At the day of vaccination (18Jun2021), the patient was tired and couldn't relax. And then she might have had a slight fever too and she felt hot, but it was hot that day too. She was sweating a little more than normal on her forehead. And her joint pain was more than normal. She had something already bothering her left foot on her toe. It seemed liked everyday for a while. She did something to her toe about 2 months now. When she standed or walked too long she felt lightheaded, but she had had that before. She might have felt a little lightheaded before she left the hospital too. She was there for 15 or 20 minutes before she left but she had someone with her. Also it was not too much of a headache, she did have some days where she felt light headed or dizzy, like when she first got up. The patient didn't want to get the Johnson and Johnson vaccine because of the things with the veins and legs and she had a lot of veins in her legs, she was hoping that Pfizer's vaccine did not affect the veins. The outcome of the events was unknown. The patient's second dose was scheduled on 09Jul2021.  Follow-up attempts are completed. No further information is expected.
Information has been received from a physician's assistant who reported that a patient came into the office and reported that a friend of hers, who was vaccinated with GARDASIL had an adverse event (not further specified, no details reported) and was hospitalized. At the time of reporting the patient's outcome was unknown. Additional information has been requested.
Extremely fatigued within 24 hours. Extremely late menstrual cycle by 10 days.
This spontaneous report as received from a 20 year old female patient with seasonal allergy refers to herself. On an unknown date the patient was vaccinated with a dose of GARDASIL dose 2, intramuscular (dose, site and lot number not provided). Concomitant therapies included SINGULAIR. On 09-JUL-2013 the patient experienced loss of hearing, back pain, chills, nausea, sore face, abdominal pain and migraine. The patient saw the doctor for medical attention. No treatment was given for the adverse events. The outcome of loss of the events was reported as not recovered. The causal relationship was not reported. Upon internal review loss of hearing was considered medically significant. Additional information is not expected.
Had fever immed. after vaccine lasting 5-6 d. 7d after vaccine went to ER for seizure. No other cause of seizure was found. 8/8/07-records received from facility for DOS 7/26-7/27/07-DC DX: Febrile Seizure. Prior to admission had been ill for about a week. Cough, decreased intake and increased fussiness. Strep throat negative. Evening of vaccine became febrile on and off for tht week. On 7/26 found in crib experiencing tonic-clonic generalized seizure. Temp 104.7.
Patient started not feeling well the next day after receiving the vaccine, she got lightheaded and had a fall, hitting her head. Her neck was sore after and she was unsure if this fainting episode was due to the vaccine or not. She followed up with her doctor, who was also unsure if the vaccine would be the cause. He ordered her an X-ray since the neck pain was still lingering.
The vial was initially stored in the refrigerator on 12-Jan-2023, Dose were administered after 11-Feb-2023; No adverse event; Dose administered after 30-day Use By Date or after manufacturer date of expiry; This spontaneous case was reported by a nurse and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Dose administered after 30-day Use By Date or after manufacturer date of expiry), PRODUCT STORAGE ERROR (The vial was initially stored in the refrigerator on 12-Jan-2023, Dose were administered after 11-Feb-2023) and NO ADVERSE EVENT (No adverse event) in an adult patient of an unknown gender who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (batch no. 065H22A) for COVID-19 prophylaxis.     No Medical History information was reported.    On 14-Feb-2023, the patient received dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Intramuscular) 1 dosage form. On 14-Feb-2023, the patient experienced EXPIRED PRODUCT ADMINISTERED (Dose administered after 30-day Use By Date or after manufacturer date of expiry). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (The vial was initially stored in the refrigerator on 12-Jan-2023, Dose were administered after 11-Feb-2023) and NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Dose administered after 30-day Use By Date or after manufacturer date of expiry), PRODUCT STORAGE ERROR (The vial was initially stored in the refrigerator on 12-Jan-2023, Dose were administered after 11-Feb-2023) and NO ADVERSE EVENT (No adverse event) outcome was unknown.        For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Intramuscular), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessments were provided for EXPIRED PRODUCT ADMINISTERED (Dose administered after 30-day Use By Date or after manufacturer date of expiry) and PRODUCT STORAGE ERROR (The vial was initially stored in the refrigerator on 12-Jan-2023, Dose were administered after 11-Feb-2023).    It was unknown patient had receive any other vaccines in the 4 weeks prior to COVID-19 vaccine. No concomitant medication was reported.   Date the vial was initially stored in the refrigerator on 12-Jan-2023.The vial did not undergo any temperature excursions. Vial size were unknown.  No treatment information was reported.   This case contains information of patient number 2 out of 8.   This case was linked to US-MODERNATX, INC.-MOD-2023-713727, US-MODERNATX, INC.-MOD-2023-713733, US-MODERNATX, INC.-MOD-2023-713731 (E2B Linked Report).; Sender's Comments:  US-MODERNATX, INC.-MOD-2023-713727:Master case (Patient 1 of 8) US-MODERNATX, INC.-MOD-2023-713731:3 of patient 8 US-MODERNATX, INC.-MOD-2023-713733:5 of Patient 8 US-MODERNATX, INC.-MOD-2023-713736:8 of patient 8 US-MODERNATX, INC.-MOD-2023-713735:7 of patient 8 US-MODERNATX, INC.-MOD-2023-713734:6 of patient 8
Initial case received from a healthcare professional (pharmacist) on 14 September 2013. A 68 year old female patient was administered FLUZONE HD vaccine, batch U4713 intramuscularly on 10 September 2013. The site of vaccination and dosage were not reported. On 10 September 2013, the same day, the patient experienced hives over her entire body and a fever. The temperature and duration was not reported. The patient saw her own healthcare professional on an unspecified date and was treated with doxycycline, dose and route not reported. The patient medical history was reported as an unspecified allergy to latex. Concomitant medications and other medical history were unknown by the reporter. Laboratory tests were not reported. The patient outcome was not recovered. Documents held by sender: None.
Information has been received from a nurse practitioner concerning a 55 year old female with recurrent bronchitis, chronic obstructive pulmonary disease, penicillin allergy and drug hypersensitivity to diazepam Valium and propoxyphene hydrochloride Darvon who on 8/1/06 was vaccinated SQ, in the right arm, with a 0.5ml dose of Pneumococcal 23v polysaccharide vaccine (lot 651173/1211R). Concomitant therapy included albuterol sulfate + ipratropium bromide Combivent, fluticasone propionate + salmeterol xinafoate Advair and albuterol. On 8/2/06 the pt developed severe headache, body aches, chills and a softball size swollen area on the right arm at the injection site. Medical attention was sought and the pt was sent to urgent care. The pts outcome was known. Severe headache, body aches, chills and inject site swelling were considered to be disabling and other important medical events (OMIC). Additional information has been requested.
Covid-19-I tested positive for Covid-19 on January 08, 2023. I experienced nausea, headaches, tiredness, no taste;  and smell, sinus pressure in face around the nose area.
Within 1 minute of receiving injection, patient described numbness in all extremities, and became verbally unresponsive. B/P of 200/100, accelerated HR. He was slumping in his chair and unable to respond though he never lost conciousness.
Vision problems; This case was reported by a pharmacist via interactive digital media and described the occurrence of abnormal vision in a adult patient who received Herpes zoster (Shingrix) for prophylaxis.   On an unknown date, the patient received the 1st dose of Shingrix. On an unknown date, 24 hrs after receiving Shingrix, the patient experienced abnormal vision. On an unknown date, the outcome of the abnormal vision was unknown.   It was unknown if the reporter considered the abnormal vision to be related to Shingrix.  Additional details were provided as follows: The age at vaccination was not reported. The patient developed vision problems about 24 hours after receiving his 1st dose of Shingrix. The patient asked is there a possibility the two are connected since the vaccine is the only thing that was different in his daily routine.
a patient received Pfizer COVID-19 vaccine, couple of days later the patient tested positive for COVID-19; a patient received Pfizer COVID-19 vaccine, couple of days later the patient tested positive for COVID-19; This is a spontaneous report from a contactable pharmacist. A patient of unspecified age and gender received the first dose of BNT162B2 (Pfizer-Biontech Covid-19 Vaccine) via an unspecified route of administration on an unspecified date at a single dose as Pfizer COVID-19 vaccine. Medical history and concomitant medications were not reported. It was reported that on an unspecified date, a patient received Pfizer COVID-19 vaccine, couple of days later the patient tested positive for COVID-19, patient subsequently received monoclonal antibody treatment: a combination of Casirivimab and Imdevimab. It was inquired if the patient could receive the second dose of COVID-19 vaccine. The outcome of the events was unknown.   Information about Lot/batch number has been requested.; Sender's Comments: Based on available information, a possible contributory role of BNT162B2 vaccine cannot be excluded for the reported events of  LOE and  COVID 19. There is very limited information provided in this report.  This case will be reassessed upon receipt of follow-up information. Based on the information provided in the case, this individual report would not seem to modify the risk-benefit profile of the subject product.
Redness, induration, tenderness right below the injection site (left arm). Symptoms continued and two day later I develop rashes on my armpits, behind knees, groins, legs and back. This is still on 4 day after the first appearance of redness/induration.
Unbeknownst to vaccinator, according to client had had one dose of Pfizer. Attempted to reach client but unable to leave message.
infestation of hives/ had her 2nd shot 5 days ago and has developed sudden welts all over her body and he believes they are hives,thinks it has gotten worse; irritating itch, thinks it has gotten worse; did not sleep at all; This is a spontaneous report from a contactable lawyer (patient husband). A 69-year-old female patient received the second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, solution for injection, Batch/Lot number: EN6201; Expiration Date: unknown), via an unspecified route of administration on 06Mar2021 (at the age of 69-year-old) as a single dose for COVID-19 immunisation. The patient had no medical history and concomitant medications. The patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, solution for injection, Batch/lot: EL9266 with EX: 5131121) on 13Feb2021 as a single dose for COVID-19 immunisation. After the second shot of vaccination on 06Mar2021, patient developed the itching and the hives began within hours of the itching. Overnight, she had huge infestation of hives/sudden welts all over her body, states it has been about 5 days since she received the 2nd dose of the Pfizer COVID19 Vaccine, believed that are hives and she had been extremely troubled with the irritating itch. Patient was at her son's house and she was feeling an itch and the thing was roaring at home after about a 30 minute drive home. Patient had a fretful night and did not sleep at all and stated that he (reporter) got up at dawn to go to the pharmacy to get what he understood to be responsive remediation for the reported event. HCP advised her to get the Benadryl tablets because topical Benadryl would not respond to that and should be in tablet form, so he got the tablet form and got the oatmeal bath and ice packs to mitigate the itch. Reporter stated that hives and itching are roaring and thinks it has gotten worse since the patient got them and it seems to be spreading and moving around her body and her whole torso was covered with the hives. Reporter enquired for how long to expect the hives, and already been too long that the patient had the hives, these side effects are supposed to last and for any recommendations to address it. The reporter assessed the events as non serious. The outcome of the event did not sleep at all was unknown and the rest of the events was not recovered.  No follow-up attempts are possible. No further information is expected.
Woke with vomiting.  Has vomited 4 times this morning. Feels warm.  Mom did not take temperature.
4/2/13 1:30 Pm Severe Pain in Left Arm and could not move arm because of the pain. Pain 12 on 0-10 scale 4/3/13 went to PCP in the morning around 10 AM 4/9/13 pain still and difficulty moving arm. Pain 6 on 0-10 scale
No adverse reactions occurred but child who was 13 months at the time was given Kinrix.  No reactions were reported.
Ringing in both ears, high pitch, non pulsating that started in the evening after the shot and continues all day through date of this reporting.
Subsequent to ZOSTAVAX inoculation, pt was treated for shingles; Information has been received from a lawyer and the consumer regarding a case in litigation referring to a female patient (pt) of unknown age. The pt's pertinent medical history, concurrent conditions and concomitant medications were not provided. In 2016, pt was inoculated with zoster vaccine live (ZOSTAVAX) by unknown route, as prescribed and/or administered by a pharmacist at a local pharmacy for the long-term prevention of shingles and/or zoster-related conditions. Subsequent to pt's zoster vaccine live (ZOSTAVAX) inoculation, on an unknown date, she was treated by a physician for shingles (herpes zoster). As a direct and proximate result of pt's use of the zoster vaccine live (ZOSTAVAX) vaccine, she had and would continue suffer ongoing injuries, including but not limited to: mental and physical pain and suffering; medical care and treatment for these injuries; significant medical and related expenses as a result of these injuries, including but not limited to medical losses and costs included care for hospitalization, physician care, monitoring, treatment, medication, and supplies; diminished capacity for the enjoyment of life; diminished quality of life; increased risk of premature death, aggravation of preexisting conditions and activation of latent conditions; and other losses and damages; and would continue to suffer such losses, and damages in the future.  At reporting time, pt was not recovered from herpes zoster and it was considered to be related to zoster vaccine live (ZOSTAVAX).
Throat swelling 10/28/10 went to ER received 50MG BENADRYL IM & 125MG SOLU-MEDROL IM. D/C home same day with Ibuprofen 600MG by mouth three times daily.
The caller refused to give any additional information regarding the adverse experience; Was given VARIVAX while pregnant; This spontaneous prospective pregnancy report was received from a consumer concerning a female patient of unknown age. Information regarding the patient's medical history, concurrent conditions and concomitant medications was not reported.       On an unknown date, the patient was vaccinated with varicella virus vaccine live (oka/merck) (VARIVAX) for prophylaxis (strength, dose, route of administration, anatomical location, lot number and expiration date were not provided) while pregnant (exposure during pregnancy). Additional information regarding the adverse experience was not reported (adverse event). The last menstrual period (LMP) and estimated date of delivery (EDD) were both not known; the pregnancy outcome was pending.   The outcome of adverse event and exposure during pregnancy was unknown.   The causality assessment between the suspect drug and the event occurrence was not reported.
Doses administered after 30-day use by date; This spontaneous case was reported by a nurse and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Doses administered after 30-day use by date) in a 46-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 027H21B) for COVID-19 vaccination.     No Medical History information was reported.    On 21-Feb-2022, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 21-Feb-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (Doses administered after 30-day use by date). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Doses administered after 30-day use by date) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medications were reported. No treatment medications were reported. The vial did not undergone any temperature excursions and Vaccine beyond use date was 16-Jan-2022. The vial was initially stored in the refrigerator was 17-Dec-2021.
pt with chronic idiopathic urticaria noted onset urticaria, flushing and itching 18 min after first covid  no angioedema no stridor no globus no wheezing no shortness of breath no chest pain no palpitation . vital sign stable exam remarkable urticaria and flushing,o/w wnl pt given oral benadryl 50mg with resolution of sx
I am unsure if this is related, but this patient developed severe hives that have lasted at least a week. She received her Moderna booster, and within two weeks, began to hive.
w/in 24hr of vax pt had 1 episode of cyanotic attack, cessation of breathing (apnea) 1-2min according to parent;mom gave mouth to mouth resuscitation w/o compression & pt started breathing;pt take to hosp by amb & observed overnoc;
Severe fatigue. Trouble getting out of bed upon wakeup. Weridness in general. Overall feeling of unsteadiness including when walking. My gait was unsteady before this shot, now its worse. Not as sharp as usual either. This vac is horrible! Take it off market! Read the reddit!
Headache, Arthralgia, Diarrhea,  chills, fatigue
Given expired vaccine; This spontaneous case was reported by a consumer and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Given expired vaccine) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 033C21A) for COVID-19 vaccination.     No Medical History information was reported.    On 05-Jul-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 05-Jul-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (Given expired vaccine). On 05-Jul-2021, EXPIRED PRODUCT ADMINISTERED (Given expired vaccine) had resolved.            No relevant concomitant medications were provided.  Treatment information was not provided.  It was reported that they received vaccine on 28-May-2021 and the vaccine use date was 27-Jun-2021 once it was refrigerated.
12 Hours after injection, major body aches lasting 12 hours, severe chills lasting 2 hours, low grade fever lasting 6-8 hours, mild headache lasting 6-8 hours.  Felt better 12-14 hours after initial symptoms
G47.33 ADULT OBSTRUCTIVE SLEEP APNEA, SEVERE 4/27/2023 HEMATEMESIS
Fever; This spontaneous case was reported by a consumer and describes the occurrence of PYREXIA (Fever) in a 65-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 047A21A) for COVID-19 vaccination.     The patient's past medical history included COVID-19 virus test positive in January 2020.    On 16-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 17-Mar-2021, the patient experienced PYREXIA (Fever). At the time of the report, PYREXIA (Fever) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No Concomitant medication were reported.  No treatment medication were reported.
This form only allows one vaccine.  My first vaccine was on 04/08/2021 and was Johnson and Johnson Janssen 043A21AZ at the Pharmacy.  It was an injection in left arm.  On 04/16/2022 At 10 pm I became blind instantaneously in my left eye.  Subsequent emergency room visit determined I had suffered Amaurosis Fugax meaning a loss of vision in one eye.  It was then determined I had suffered a Central Retinal Vein occlusion.  I have been treated five times by Retinal specialists with eyelea shots and my vision is partially restored.  I have had multiple CT scans of my brain, ultra sounds of my heart, MRIs.  It has been determined that my tests are normal and nothing associated with those tests caused this.
Got Covid too; Runny nose; Cough; Dizzy; Sore arm at the injection site; This spontaneous case was reported by a consumer and describes the occurrence of COVID-19 (Got Covid too), RHINORRHOEA (Runny nose), COUGH (Cough), DIZZINESS (Dizzy) and VACCINATION SITE PAIN (Sore arm at the injection site) in a 73-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 011D21A) for COVID-19 vaccination.     No Medical History information was reported.    On 07-Aug-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 07-Aug-2021, the patient experienced VACCINATION SITE PAIN (Sore arm at the injection site). On 20-Aug-2021, the patient experienced COVID-19 (Got Covid too), RHINORRHOEA (Runny nose), COUGH (Cough) and DIZZINESS (Dizzy). At the time of the report, COVID-19 (Got Covid too), RHINORRHOEA (Runny nose), COUGH (Cough), DIZZINESS (Dizzy) and VACCINATION SITE PAIN (Sore arm at the injection site) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medication were reported. No treatment information was provided by the reporter.  Reporter stated that the patient got covid and patient didn't get tested.